Advanced Chemistry Development Announces Agreement with Fujitsu Limited to Expand Distribution in Japan
Chiba, Japan, and Toronto, Canada, March 12, 2002 -
Fujitsu Limited (Fujitsu) and Advanced Chemistry Development, Inc. (ACD) announce their agreement, which establishes Fujitsu as the master distributor of ACD software in Japan.
Fujitsu will, under the new agreement, distribute ACD's entire portfolio of software solutions to the chemistry-based research industry throughout Japan. "This joint initiative with Fujitsu expands ACD's marketing reach in Japan significantly, and enhances our customer support capabilities in this important market," said Ian Dugdale, Director of Sales for ACD.
Based on data from the Mitsubishi Research Institute on the biotechnology sector, the pharmaceutical and chemicals markets in Japan were valued at $3 billion US and $2 billion US respectively in 1999. Overall, the biotechnology sector in Japan was estimated to be growing at an annual rate of 24%. The agreement with Fujitsu presents ACD with a tremendous opportunity to place a new focus on the Japanese market, and to increase their market share within a rapidly growing industry. "In the past year, ACD has been recognized as one of North America's fastest growing technology companies because of the positive impact our software brings to scientists. Now, with expanded presence in Japan, we will be able to bring this benefit to new users in the years to come," said Tony Williams, Ph.D., VP of Scientific Development and Marketing at ACD.
Fujitsu has been in the computational chemistry, chem-informatics, and bio-informatics business since the early 1980's. Fujitsu has established a solid track record in the pharmaceutical industry, offering solutions comprising software packages, systems integration, and operational services for the many steps in the drug development process.
ACD's innovative software solutions combined with Fujitsu's breadth of experience in the pharmaceutical industry will enable both ACD and Fujitsu to better position themselves with key contenders in Japan's chemistry-based research industry. "We are excited about the opportunity to do business with Fujitsu. Our intention is to attain the highest standards of service and support to our existing and prospective customers in Japan," said Val Kulkov, M.Sc., President and CEO of ACD.
About Advanced Chemistry Development
Advanced Chemistry Development (ACD) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information. ACD creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, and chemical patenting and publication. Combined, ACD's solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD employs a team of over 100 dedicated individuals whose continual efforts carry ACD's innovative technologies into pharmaceutical, biotech, chemical and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
About Fujitsu Limited
Fujitsu is a leading provider of Internet-focused information technology solutions for the global marketplace. Its pace-setting technologies, best-in-class computing and telecommunications platforms, and worldwide corps of systems and services experts make it uniquely positioned to unleash the infinite possibilities of the Internet to help its customers succeed. Headquartered in Tokyo, Fujitsu Limited reported consolidated revenues of 5.48 trillion yen for the fiscal year ended March 31, 2001. For further information, please visit the Fujitsu Limited home page at www.fujitsu.com, or contact Munetaka Sawada of the Life Science and Material Science Division at msawada@strad.ssg.fujitsu.com.
|
